quasispeci
dynam
mediat
adapt
rna
virus
number
mechan
review
present
articl
emphasi
medic
implic
hepat
virus
discuss
replic
nonrepl
molecular
mechan
genom
variat
modul
effect
mutant
spectra
sever
mode
viral
evolut
affect
viral
pathogenesi
relev
evolutionari
event
includ
gener
minor
viru
variant
alter
function
properti
alter
mutant
spectrum
complex
affect
diseas
progress
respons
treatment
widespread
occurr
resist
antivir
drug
encourag
new
strategi
control
hepat
viral
diseas
combin
therapi
lethal
mutagenesi
particular
ribavirin
may
exert
case
antivir
activ
particip
mutagen
action
despit
mani
unansw
question
document
quasispeci
dynam
provid
interpret
adapt
hepat
virus
featur
conceptu
similar
observ
rna
virus
reflect
common
underli
darwinian
principl
genet
phenotyp
variat
virus
intim
associ
mechan
viral
pathogenesi
genet
biochem
immunolog
enzymolog
evolut
studi
appli
mani
differ
virus
settl
conclus
virus
rna
either
genet
materi
replic
intermedi
share
high
mutat
rate
quasispeci
dynam
genet
biochem
method
contribut
measur
mutat
rate
frequenc
quantifi
differ
activ
among
variant
form
viral
gene
product
immunolog
defin
phenotyp
variat
relev
trait
virushost
interact
antigen
variat
particip
viru
escap
antibodi
cytotox
lymphocyt
ctl
viral
persist
diseas
progress
enzymolog
studi
viruscod
polymeras
provid
insight
molecular
basi
errorpron
replic
studi
evolut
shown
high
error
rate
mere
consequ
rapid
rna
genom
replic
adapt
valu
origin
quasispeci
dynam
bear
understand
viral
diseas
recent
overview
viral
quasispeci
see
differ
chapter
domingo
tabl
articl
summar
mechan
viral
genom
variat
quasispeci
dynam
special
refer
hepat
virus
display
high
mutat
rate
quasispeci
dynam
agreement
use
rna
genet
materi
replic
intermedi
includ
hepat
c
delta
agent
subvir
pathogen
requir
hepat
b
viru
helper
viru
e
g
virus
origin
gb
viru
isol
tamarin
monkey
inocul
human
serum
later
clone
gbva
gbvb
passag
tamarin
serum
gbvc
hepat
g
viru
human
serum
virus
abbrevi
hav
hcv
hdv
hev
gbva
gbvb
gbvc
hgv
respect
tabl
featur
viral
quasispeci
viru
popul
spectrum
mutant
mutant
spectra
may
includ
phenotyp
variant
contribut
viru
adapt
subpopul
bear
biolog
relev
distinct
mutat
may
coexist
infect
individu
host
compon
mutant
spectra
show
differ
fit
level
fit
variat
occur
viral
popul
depend
passag
regim
popul
size
environment
chang
fit
gradient
guid
movement
sequenc
space
quasispeci
dynam
deleteri
neutral
advantag
per
se
directli
compensatori
mutat
occur
compon
mutant
spectrum
detriment
advantag
natur
depend
environ
replic
take
place
sequenc
context
level
individu
genom
level
surround
mutant
spectrum
broad
mutant
spectrum
contribut
viru
adapt
narrow
broad
spectrum
may
impair
adapt
mutat
rate
critic
error
threshold
result
loss
infect
mutant
spectrum
modul
viru
behavior
posit
interact
complement
neg
interact
interfer
domin
neg
interact
contribut
viral
extinct
high
fit
mutant
suppress
mutant
spectrum
inferior
fit
low
fit
viru
may
resist
mutat
higher
fit
counterpart
former
lie
flat
fit
surfac
latter
sharp
fit
peak
base
domingo
domingo
eigen
eigen
biebrich
refer
quot
articl
volum
gbva
gbvb
gbvc
univers
regard
activ
agent
hepat
diseas
cover
interest
model
system
evolutionari
studi
agent
occasion
associ
hepat
diseas
ie
enterovirus
herpesvirus
etc
includ
articl
biochem
basi
errorpron
replic
rnadepend
rna
polymeras
rdrp
rnadepend
dna
polymeras
rddp
revers
transcriptas
rt
character
date
lack
domain
correspond
exonucleolyt
activ
capabl
excis
incorrectli
incorpor
nucleotid
produc
mismatch
grow
end
allow
incorpor
correct
nucleotid
basepair
templat
exonucleolyt
activ
term
proofreadingrepair
activ
absenc
rdrp
rddp
document
structur
biochem
studi
ferrerorta
et
al
friedberg
et
al
steinhauer
et
al
steitz
recent
domain
correspond
exonucleas
identifi
character
coronavirus
exo
n
sar
coronaviru
exonucleolyt
function
play
essenti
role
coronaviru
rna
replic
possibl
contribut
rna
copi
fidel
demonstr
yet
minskaia
et
al
copi
fidel
rdrp
rddp
determin
rel
rate
incorpor
correct
versu
incorrect
nucleotid
recent
studi
viral
enzym
review
arnold
et
al
averag
error
rate
rna
virus
rang
misincorpor
per
nucleotid
copi
batschelet
et
al
drake
holland
mutant
viral
polymeras
display
either
increas
decreas
copi
fidel
due
specif
amino
acid
replac
character
arnold
et
al
manski
et
al
pfeiffer
kirkegaard
vignuzzi
et
al
consequ
errorpron
replic
affect
catalyt
properti
viral
polymeras
alter
error
rate
subject
select
arnold
et
al
cellular
dnadepend
dna
polymeras
dddp
well
dddp
encod
complex
dna
virus
poxvirus
herpesvirus
adenovirus
includ
proofreadingrepair
activ
latter
togeth
number
protein
present
dna
replic
complex
decreas
error
rate
substitut
per
nucleotid
cellular
dna
synthesi
friedberg
et
al
addit
proofreadingrepair
number
postrepl
mismatch
repair
dna
damag
signal
pathway
oper
doublestrand
dna
reduc
overal
error
rate
misincorpor
per
nucleotid
copi
standard
dna
replic
friedberg
et
al
postrepl
repair
activ
either
inact
ineffici
doublestrand
rna
dnarna
hybrid
found
replic
intermedi
ribovirus
retrovirus
hepadnavirus
relev
larg
unansw
question
whether
protein
involv
repair
function
access
viral
dna
genom
replic
depend
intracellular
site
dna
genom
replic
well
stoichiometri
avail
repair
protein
relat
number
viral
dna
genom
replic
factori
postrepl
repair
function
may
ineffici
also
viral
dna
possibl
limit
postrepl
correct
togeth
type
molecular
mechan
involv
dna
replic
predomin
singlestrand
doublestrand
dna
form
whether
low
fidel
high
fidel
dddp
catalys
nucleotid
incorpor
determin
error
rate
level
viral
dna
replic
review
domingo
evid
dna
virus
limit
genet
complex
share
rna
virus
great
genet
heterogen
potenti
rapid
adapt
exampl
anim
parvovirus
et
al
et
al
plant
geminivirus
isnard
et
al
extent
simpl
complex
dna
virus
exploit
local
gener
high
mutat
rate
extent
genet
variat
affect
pathogen
import
question
requir
addit
research
sourc
mutat
viral
genom
cellular
edit
enzym
adar
apobec
famili
nucleic
acid
deaminas
constitut
part
innat
defens
mechan
viral
infect
sheehi
et
al
apobec
cytidin
deaminas
act
singl
strand
dna
lead
g
c
u
hypermut
adar
adenosin
deaminas
act
doubl
strand
viral
rna
lead
g
u
c
hypermut
review
chiu
green
valent
nishikura
cellular
deaminas
activ
involv
diversif
immunoglobulin
gene
exampl
protein
aid
member
apobec
famili
mrna
trna
edit
thu
contribut
gener
rna
protein
divers
schaub
keller
face
viral
infect
part
innat
antivir
host
respons
viral
protein
evolv
counteract
hypermutagen
activ
cellular
deaminas
vif
bind
prevent
encapsid
deaminas
viral
particl
subsequ
hypermutagen
activ
minu
strand
dna
sever
protein
associ
capsid
hbv
mediat
hypermutagenesi
viral
genom
applic
differenti
dna
denatur
pcr
techniqu
suspen
et
al
hbv
genom
rescu
coelectropor
cell
dna
express
apobec
protein
reveal
genom
g
hypermut
mediat
apobec
c
hypermut
mediat
apobec
result
inhibit
hbv
replic
bonvin
et
al
suspen
et
al
hypermut
genom
detect
sera
patient
acut
chronic
hbv
infect
noguchi
et
al
suspen
et
al
suspen
et
al
except
hypermut
genom
gener
defect
hypermut
regard
unregul
defens
respons
use
enzym
play
key
physiolog
role
host
cell
howev
constitut
express
adar
adar
contribut
edit
specif
nucleotid
hdv
antigenom
rna
edit
event
allow
express
delta
antigen
l
singl
openread
frame
essenti
maintain
hdv
infect
hartwig
et
al
sato
et
al
secondari
structur
target
rna
appear
play
import
role
direct
edit
activ
specif
rna
residu
dawson
et
al
mutat
may
also
result
chemic
damag
viral
genom
deamin
depurin
depyrimidin
reaction
oxygen
radic
direct
indirect
effect
ioniz
radiat
photochem
reaction
friedberg
et
al
naeg
togeth
mutat
activ
cellular
deaminas
differ
mechan
sometim
refer
nonrepl
mechan
viral
genom
mutat
avail
evid
support
errorpron
replic
major
sourc
mutat
viral
genom
includ
hepat
virus
second
widespread
mechan
viral
genom
variat
recombin
sever
form
molecular
recombin
recogn
homolog
nonhomolog
replic
nonrepl
review
chetverin
et
al
domingo
gmyl
et
al
nagi
simon
homolog
recombin
extens
nucleotid
sequenc
ident
two
parent
genom
around
crossov
site
nonhomolog
recombin
associ
substanti
nucleotid
sequenc
ident
replic
recombin
requir
viral
genom
replic
occur
nonrepl
recombin
discov
rna
virus
upon
cotransfect
cell
viral
rna
fragment
replic
gallei
et
al
gmyl
et
al
common
form
homolog
replic
recombin
probabl
oper
dna
rna
virus
copi
choic
templat
switch
involv
detach
templat
polymeras
complex
nascent
product
continu
copi
process
posit
anoth
templat
molecul
recombin
intermolecular
involv
two
differ
templat
molecul
copi
choic
mechan
intramolecular
lead
intern
delet
synthesi
defect
genom
includ
defect
interf
di
rna
encapsid
di
particl
roux
et
al
defect
genom
increasingli
recogn
activ
particip
evolutionari
behaviour
viral
popul
review
domingo
differ
virus
exploit
recombin
differ
extent
either
exploratori
activ
produc
new
genom
combin
mean
rescu
viabl
genom
parent
genom
debilit
mutat
host
protein
endoribonucleas
exoribonucleas
may
modul
recombin
frequenc
inher
polymer
machineri
cheng
et
al
servien
et
al
recombin
character
sever
hepat
virus
bollyki
et
al
costamattioli
et
al
cristina
colina
gaussmul
kusov
kalinina
et
al
noppornpanth
et
al
wang
chao
yang
et
al
therefor
ad
recombin
mutat
mechan
genom
variat
import
group
pathogen
virus
segment
genom
case
hepat
virus
describ
far
segment
reassort
provid
addit
mechan
genet
phenotyp
variat
mutat
univers
recombin
mani
case
constitut
basic
variat
mechan
preced
intrahost
interhost
evolutionari
event
also
case
hepat
virus
understand
quasispeci
dynam
affect
intrahost
adapt
rna
virus
gener
hepat
virus
particular
requir
mutat
rate
distinguish
mutat
frequenc
state
mayr
outcom
select
two
step
process
mutat
select
express
mutat
rate
mutat
frequenc
term
mutat
rate
quantifi
biochem
event
misincorpor
incorpor
one
incorrect
nucleotid
copi
viral
nucleic
acid
templat
mutat
rate
independ
fate
increas
decreas
proport
mutat
progeni
produc
rel
nonmut
version
gener
refer
specif
nucleotid
site
may
describ
specif
misincorpor
one
type
incorrect
nucleotid
misincorpor
type
incorrect
nucleotid
site
mutat
rate
averag
multipl
site
express
number
substitut
per
nucleotid
copi
contrast
mutat
rate
mutat
frequenc
quantif
proport
mutant
genom
viral
genom
popul
accordingli
express
substitut
per
nucleotid
mutat
frequenc
may
refer
proport
specif
mutant
type
often
term
mutant
frequenc
type
mutant
term
mutat
frequenc
mutat
mutant
frequenc
influenc
capac
mutant
produc
progeni
rel
capac
nonmut
class
mutant
produc
replic
ensembl
specif
mutat
may
gener
high
rate
biochem
reason
sequenc
context
templat
may
found
low
frequenc
inflict
fit
cost
impos
select
disadvantag
upon
genom
harbour
yet
note
regard
viral
pathogenesi
mutat
may
inflict
fit
cost
viru
replic
organ
infect
host
replic
anoth
organ
tissu
cell
type
advantag
neutral
deleteri
lethal
natur
mutat
thu
conserv
variat
genom
nucleotid
rel
given
physic
biolog
environ
tabl
strike
illustr
exampl
extens
studi
colleagu
frequent
gener
intern
oligoadenyl
tract
genom
picornaviru
footandmouth
diseas
viru
fmdv
belong
famili
hav
viru
subject
plaquetoplaqu
transfer
despit
entail
signific
fit
cost
viru
reason
fmdv
rdrp
appear
biochem
instruct
gener
intern
oligoadenyl
describ
natur
isol
anim
viru
found
plant
virus
probabl
propens
toward
slippag
mutagenesi
also
term
polymeras
stutter
four
success
adenyl
residu
complementari
uridyl
residu
minu
strand
rna
preced
second
function
aug
codon
current
evid
suggest
plaquetoplaqu
transfer
neg
select
elimin
unfit
genom
less
intens
larg
popul
passag
involv
pronounc
competit
among
genom
cours
repeat
plaquetoplaqu
transfer
biochem
instruct
prevail
select
review
aspect
rna
genet
see
et
al
mutat
frequenc
popul
number
may
actual
close
correspond
mutat
rate
replic
capac
mutant
gener
differ
substanti
ensembl
number
round
replic
occurr
mutat
detect
popul
genom
limit
technic
detail
calcul
use
deriv
mutat
rate
frequenc
must
examin
care
publish
valu
use
claim
low
mutat
rate
rna
virus
realiti
base
extrapol
frequenc
subset
advantag
neutral
mutat
exampl
score
individu
viral
plaqu
exclud
deleteri
mutat
often
abund
viru
replic
examin
claim
unusu
low
mutat
rate
high
polymeras
copi
fidel
rna
viru
base
mutat
frequenc
reader
consid
outstand
low
valu
substitut
per
nucleotid
may
mean
either
select
disadvantag
genom
harbor
mutat
calcul
base
b
requir
two
mutat
alter
phenotyp
trait
measur
frequenc
occurr
n
mutat
genom
obtain
multipli
frequenc
occurr
individu
mutat
thu
averag
frequenc
one
mutat
tripl
mutant
expect
frequenc
c
gener
sitespecif
high
polymeras
fidel
aris
definit
interest
regard
molecular
basi
convers
high
mutat
frequenc
dna
viru
whose
replic
catalyz
high
fidel
dddp
main
mean
either
repair
activ
function
b
mutant
overgrow
wild
type
due
select
constraint
fit
advantag
prior
measur
frequenc
mathemat
treatment
calcul
mutat
rate
take
account
revers
low
fit
mutant
competit
wild
type
publish
deriv
origin
equat
propos
batschelet
et
al
academ
consider
import
latter
relev
concept
appreci
full
extent
biolog
relev
high
mutat
rate
quasispeci
dynam
featur
rna
virus
gener
hepat
virus
particular
replic
host
contribut
diseas
despit
difficulti
limit
nuanc
deriv
interpret
mutat
rate
frequenc
independ
genet
biochem
method
support
mutat
frequenc
rna
virus
rang
substitut
per
nucleotid
averag
total
valu
ribovirus
retrovirus
hepadnavirus
obtain
differ
laboratori
domingo
much
broader
rang
obtain
eukaryot
prokaryot
dna
virus
valu
around
complex
bacteriophag
parvovirus
domingo
et
al
anoth
appropri
distinct
must
made
mutat
rate
rate
evolut
also
term
rate
accumul
fixat
mutat
latter
gener
calcul
compar
consensu
sequenc
sequenti
viral
isol
includ
time
factor
commonli
express
substitut
per
nucleotid
year
compil
differ
measur
rna
virus
show
valu
fall
rang
substitut
per
nucleotid
year
sni
outstandingli
high
sni
low
sni
valu
domingo
rate
evolut
estim
hcv
rang
sni
abe
et
al
lu
et
al
ogata
et
al
okamoto
et
al
smith
et
al
hgv
sni
barcon
et
al
nakao
et
al
broader
rang
sni
determin
delta
antigen
imazeki
et
al
lee
et
al
valu
hdv
show
defect
viru
evolv
rate
compar
nondefect
standard
virus
document
also
rapid
evolut
subvir
replicon
unfortun
time
rate
evolut
refer
mutat
rate
confus
terminolog
partli
deriv
classic
popul
genet
consid
key
distinct
mutat
rate
biochem
mean
readili
observ
rate
evolut
overlook
distinct
obscur
import
properti
viral
popul
particularli
implic
dynam
genet
heterogen
viral
diseas
irrespect
intrahost
interhost
rate
evolut
measur
consensu
genom
sequenc
select
random
drift
act
essenti
heterogen
popul
push
transmiss
event
lead
diversif
consensu
sequenc
group
type
subtyp
variant
diversif
dynam
process
epidemiolog
activ
viru
number
type
subtyp
either
genet
antigen
increas
time
current
hcv
isol
differ
genotyp
correspond
show
averag
nucleotid
sequenc
similar
genom
rang
differ
subtyp
show
nucleotid
sequenc
similar
compon
mutant
spectrum
quasispeci
clementi
boundari
rather
arbitrari
may
requir
period
updat
applic
virus
particular
viral
quasispeci
may
produc
diverg
outlier
explor
sequenc
space
extent
diverg
vari
differ
genom
region
hcv
glycoprotein
code
region
may
differ
nucleotid
among
independ
isol
even
protein
subdomain
analyz
clementi
procedur
determin
mutant
spectrum
complex
viral
quasispeci
previous
review
domingo
et
al
three
common
paramet
calcul
mutat
frequenc
defin
proport
mutant
nucleotid
genom
distribut
rel
consensu
sequenc
ii
shannon
entropi
defin
proport
differ
genom
mutant
distribut
iii
genet
distanc
also
term
ham
distanc
defin
number
mutat
distinguish
two
sequenc
distribut
averag
possibl
pair
reflect
genet
complex
three
paramet
calcul
nucleotid
sequenc
deriv
molecular
clone
biolog
clone
viru
produc
plaqu
foci
cell
cultur
direct
calcul
well
precaut
avoid
bias
valu
complex
discuss
domingo
et
al
methodolog
origin
use
defin
analys
quasispeci
structur
rna
genet
element
direct
sampl
nucleotid
sequenc
rna
fingerprint
case
hepat
virus
mani
anim
virus
genom
rna
examin
directli
concentr
serum
biolog
sampl
often
low
altern
rapid
sampl
procedur
use
compar
rel
genet
heterogen
viral
popul
includ
restrict
enzym
site
polymorph
heteroduplex
mobil
assay
ribonucleas
mismatch
cleavag
oligonuclotid
map
microarray
techniqu
independ
method
confirm
extens
heterogen
rna
viru
popul
particularli
popul
hcv
infect
patient
first
error
rate
frequenc
rna
virus
obtain
met
skeptic
due
high
valu
histor
account
see
holland
although
gener
high
mutat
rate
wide
accept
today
argu
due
detriment
natur
mutat
adapt
valu
rna
viru
extrem
mutat
rate
care
reconsid
suggest
exist
tradeoff
replic
effici
copi
fidel
view
high
mutat
rate
consequ
rapid
rna
replic
increas
copi
fidel
would
come
cost
result
lower
replic
rate
studi
high
fidel
mutant
polioviru
pfeiffer
kirkegaard
vignuzzi
et
al
document
mutant
replic
slightli
lower
rate
wild
type
viru
cell
cultur
strong
select
disadvantag
regard
invas
brain
suscept
mice
control
experi
show
impedi
caus
neuropatholog
due
limit
complex
mutant
spectrum
viru
replic
mice
thu
case
high
mutat
rate
broad
mutant
spectrum
essenti
viru
adapt
complex
environ
provid
host
organ
requir
intern
popul
structur
viral
quasispeci
adapt
new
chang
environ
expect
depend
natur
select
constraint
confront
viral
popul
adapt
singl
antivir
inhibitor
often
repres
highli
specif
select
pressur
direct
defin
viral
target
may
compat
rang
mutat
rate
mutant
spectrum
complex
similar
even
level
commonli
seen
viral
popul
keulen
et
al
lower
standard
typic
wild
type
viru
mutat
rate
may
suffici
one
mutat
caus
decreas
sensit
viru
inhibitor
incident
eas
deriv
resist
antivir
inhibitor
particular
nucleosid
analogu
often
associ
singl
amino
acid
substitut
relev
enzym
may
ancient
evolutionari
basi
need
primit
replic
system
cope
inhibitori
metabolit
possibl
discuss
previous
connect
quasispeci
drug
resist
see
domingo
previou
version
articl
contrast
success
adapt
respons
achiev
limit
genet
variat
adapt
complex
environmentssuch
may
need
invad
new
organ
cours
intrahost
replic
may
requir
number
constel
multipl
mutat
case
high
mutat
rate
complex
mutant
spectrum
may
confer
select
advantag
viru
may
becom
imper
longterm
surviv
remark
increas
evid
suggest
constel
mutat
requir
adapt
may
locat
either
genom
molecul
number
differ
genom
may
complement
requir
rich
broad
complex
mutant
spectrum
moreno
et
al
pfeiffer
kirkegaard
vignuzzi
et
al
standard
mutat
rate
valu
record
mani
rna
virus
domingo
may
inherit
primit
proteinmedi
replic
system
may
outcom
adapt
extend
episod
coevolut
host
complex
variabl
environ
although
addit
experi
need
gener
possibl
adapt
advantag
complex
mutant
spectra
current
experiment
evid
support
adapt
valu
high
mutat
rate
rna
virus
independ
rate
viral
rna
synthesi
obvious
exclud
high
low
fidel
mutant
could
found
manifest
also
substanti
alter
rate
rna
synthesi
like
howev
copi
fidel
result
multipl
factor
addit
studi
necessari
assess
extent
replic
rate
one
knowledg
acquir
life
cycl
sever
virus
taught
us
rapid
replic
trait
univers
select
among
rna
virus
virus
evolv
capac
produc
acut
chronic
latent
persist
symptomat
asymptomat
infect
wide
differ
time
cours
borna
diseas
viru
usual
produc
net
yield
less
one
progeni
genom
per
infect
cell
vivo
hav
slow
replic
despit
genom
organ
similar
fastest
replic
picornavirus
hav
exploit
rare
codon
modul
translat
rate
limit
overal
replic
rate
better
biolog
effici
et
al
import
dispel
notion
rapid
replic
evolv
univers
necess
virus
high
mutat
rate
unavoid
perhap
unneed
consequ
mutat
rate
frequenc
rna
virus
section
mean
occurr
mutat
occasion
continu
unavoid
case
rna
genom
replic
believ
one
major
chang
emphasi
last
decad
regard
understand
virus
popul
level
consensu
viral
genom
sequenc
remain
invari
mutat
occur
methodolog
sequenc
determin
identifi
weight
averag
multitud
relat
sequenc
overlook
intrapopul
heterogen
rna
virus
kb
genom
averag
mutat
introduc
templat
copi
expect
addit
sinc
mutat
affect
viral
polymeras
sever
polymeras
residu
may
exert
effect
templat
copi
fidel
section
mutat
rate
substrat
select
therefor
mutat
rate
modul
viral
function
earl
deem
high
mutat
rate
must
ad
rapid
turnov
viral
particl
vivo
notabl
case
hcv
hbv
review
pawlotski
exampl
infect
adult
averag
new
hcv
virion
per
day
produc
neumann
et
al
reflect
probabl
minor
subset
hcv
replic
event
occur
day
one
infect
host
given
frequent
infect
cell
multipl
often
thousand
viral
genom
complementari
strand
copi
templat
replic
ensembl
consist
dynam
distribut
relat
sequenc
subject
continu
genet
variat
competit
select
dynam
distribut
term
viral
quasispeci
fig
quasispeci
initi
develop
determinist
theori
molecular
evolut
manfr
eigen
peter
schuster
explain
selforgan
earli
evolut
life
earth
eigen
schuster
theori
extend
finit
popul
chang
environ
eigen
eigen
saakian
hu
wilk
et
al
includ
recombin
mechan
genet
variat
boerlijst
et
al
gener
determinist
model
formul
place
problem
gener
context
solvabl
mathemat
term
stochast
extens
allow
closer
approxim
realiti
model
includ
quasispeci
evolut
face
host
immun
respons
kamp
quasispeci
one
sever
possibl
theoret
formul
darwinian
evolutionari
dynam
page
nowak
adequ
interpret
behaviour
replic
system
display
high
mutat
rate
conflict
altern
model
classic
popul
genet
wilk
featur
quasispeci
dynam
summar
tabl
reader
find
updat
review
theoret
concept
appli
virus
biebrich
eigen
biebrich
eigen
biolog
implic
quasispeci
figlerowicz
et
al
multipl
viral
quasispeci
coexist
infect
host
differ
replic
site
success
time
point
offer
rich
substrat
intern
interact
within
quasispeci
occasion
interact
quasispeci
select
random
event
act
upon
infect
organ
repres
true
exampl
biolog
complex
inher
emerg
et
al
novella
novella
et
al
figur
modifi
permiss
behavior
unpredict
recent
review
domingo
domingo
one
predict
quasispeci
theori
mutant
could
domin
fitter
one
virtu
surround
favour
close
relat
mutant
spectrum
eigen
biebrich
swetina
schuster
suppress
mutant
mutant
spectrum
even
interpret
triumph
mean
fittest
gomez
cacho
shown
experiment
first
time
vesicular
stomat
viru
vsv
cell
cultur
de
la
torr
holland
mutant
present
minimum
express
threshold
level
overcom
suppress
mutant
spectrum
suppress
effect
document
sever
virushost
system
cell
cultur
vivo
domingo
domingo
express
threshold
level
systemat
measur
expect
environmentdepend
surround
mutant
spectrum
key
featur
environ
suppress
interf
effect
mutant
spectra
appear
increas
mutat
rate
viral
quasispeci
suggest
strong
suppress
effect
infect
viral
popul
close
extinct
driven
enhanc
mutagenesi
et
al
et
al
interfer
class
defect
genom
term
defector
propos
contribut
viral
extinct
enhanc
mutagenesi
viru
entri
error
catastroph
lethal
mutagenesi
review
section
effect
necessit
coinfect
cell
multipl
viru
variant
latter
gener
within
infect
cell
virus
evid
multipl
particl
infect
suscept
cell
vivo
cell
subset
may
prone
multipl
infect
cicinsain
et
al
chohan
et
al
suppress
effect
togeth
opposit
complement
potenti
among
compon
mutant
spectrum
anoth
demonstr
quasispeci
behavior
understood
mere
sum
behavior
individu
compon
consid
isol
thu
quasispeci
often
defin
dynam
genom
distribut
subject
variat
competit
select
act
unit
select
quasispeci
theori
adapt
studi
virus
popul
implic
longterm
evolut
virus
viral
pathogenesi
implic
viru
evolut
substrat
posit
select
neg
select
random
drift
defin
genom
type
mutant
cloud
implic
viral
pathogenesi
specif
type
variant
either
permit
surviv
viru
differ
compart
infect
host
establish
interact
host
compon
may
lead
diseas
fact
connect
viral
evolut
viral
diseas
even
complex
mani
facet
examin
next
relev
quasispeci
viru
adapt
surviv
stem
two
distinct
featur
rapid
gener
divers
suppli
phenotyp
variant
escap
mutant
effect
mutant
spectra
per
se
may
endow
viral
popul
properti
attribut
specif
variant
interestingli
implic
quasispeci
also
observ
play
hepat
virus
even
popul
hav
despit
remark
antigen
invari
contain
spectra
mutant
substrat
select
genet
diversif
et
al
howev
extens
studi
quasispeci
vivo
carri
hcv
hcv
quasispeci
first
detect
describ
infect
patient
fifteen
year
ago
martel
et
al
sinc
report
patient
acut
chronic
infect
farci
et
al
honda
et
al
koizumi
et
al
kurosaki
et
al
yuki
et
al
blood
donortorecipi
esteban
et
al
hohn
et
al
kojima
et
al
ma
et
al
mothertobabi
pair
farci
et
al
weiner
et
al
well
varieti
biolog
sampl
includ
serum
peripher
blood
mononuclear
cell
liver
specimen
cabot
et
al
pal
et
al
addit
found
genom
antigenom
rna
strand
togeth
presenc
hcv
quasispeci
tissu
viru
found
differ
stage
infect
clinic
situat
examin
render
quasispeci
structur
hcv
inher
properti
viru
properti
manner
viru
take
advantag
potenti
studi
two
perspect
relat
clinic
featur
infect
transmiss
persist
liver
damag
respons
treatment
review
pawlotski
b
context
studi
either
attempt
deciph
key
point
biolog
life
cycl
viru
confront
immun
system
direct
toward
develop
new
therapeut
strategi
although
connect
viru
evolut
diseas
mechan
multipl
exceedingli
complex
beyond
expertis
scope
articl
tent
identifi
unavoid
simplif
least
three
evolutionari
event
impact
viral
pathogenesi
gener
mutant
escap
select
pressur
deriv
either
host
immun
respons
extern
intervent
b
evolut
toward
increas
decreas
virul
associ
specif
genet
modif
viral
genom
c
diseas
potenti
modifi
composit
complex
mutant
spectrum
next
section
review
gener
implic
specif
mutant
popul
complex
special
refer
hepat
virus
previou
review
see
clementi
esteban
et
al
pawlotski
phenotyp
chang
virus
mediat
singl
nucleotid
amino
acid
substitut
adapt
valu
minim
genet
chang
produc
genom
copi
machineri
entail
fit
cost
intens
decreas
proport
mutant
minimum
express
threshold
level
see
section
requir
fulfil
mutant
repres
quasispeci
frequenc
phenotyp
trait
associ
mutant
expos
select
event
frequent
viral
mutant
type
antibodi
cytotox
lymphocyt
ctl
inhibitorescap
mutant
hcv
variat
hypervari
region
glycoprotein
presum
due
antibodi
ab
select
associ
develop
hcv
persist
human
farci
et
al
avail
cell
cultur
system
hcv
open
possibl
studi
capac
ab
neutral
hcv
approach
dynam
select
escap
mutant
previous
document
virus
variat
antigen
determin
associ
case
antihbv
vaccin
failur
review
amino
acid
substitut
protein
frequent
among
human
carrier
seroposit
anti
antibodi
yamamoto
et
al
relev
hbv
antigen
mutant
epidemiolog
level
suggest
increas
preval
mutant
follow
antihb
vaccin
children
hsu
et
al
clonal
analysi
viral
sequenc
chronic
hbv
carrier
document
coexist
hepat
b
surfac
hb
antigen
antihb
antibodi
associ
increas
determin
heterogen
substitut
describ
immun
escap
variant
lada
et
al
analys
suggest
select
immuneescap
hbv
variant
chronic
hbv
infect
constitut
exampl
biolog
relev
coexist
phenotyp
variant
host
individu
tabl
chronic
infect
patient
often
includ
substitut
ctl
epitop
hbv
tai
et
al
ctlescap
mutant
hcv
implic
viral
persist
describ
infect
chimpanze
studi
suggest
respons
focus
epitop
emerg
escap
mutant
promot
viral
persist
wherea
earli
broad
respons
favor
viral
clearanc
cooper
et
al
erickson
et
al
weiner
et
al
increas
evid
involv
ctlescap
mutant
hcv
persist
human
chang
et
al
timm
et
al
review
bowen
walker
similar
observ
made
regard
clonal
immun
respons
hbv
select
escap
mutant
margeridon
et
al
contribut
mutant
evad
recognit
helper
lymphocyt
cytotox
lymphocyt
viral
persist
describ
sever
virushost
system
ciurea
et
al
goulder
et
al
kawada
et
al
koenig
et
al
art
number
mechan
ctlescap
identifi
review
bowen
walker
amino
acid
substitut
diminish
abolish
bind
epitop
mhc
class
molecul
mhcpeptid
complex
express
recogn
cell
receptor
tcr
b
amino
acid
replac
alter
intracellular
process
viral
protein
lead
peptid
bind
effici
mhc
class
molecul
c
presenc
substitut
epitop
may
antagon
respons
wild
type
epitop
antagonist
effect
variant
epitop
peptid
rais
broader
question
possibl
modul
effect
nonident
antigen
structur
express
mutant
spectra
viral
quasispeci
extrem
case
repres
reinfect
human
differ
dengu
viru
serotyp
may
result
bias
cytokin
respons
contribut
sever
dengu
virusassoci
patholog
mongkolsapaya
et
al
mongkolsapaya
et
al
chronic
infect
multipl
relat
viral
protein
sequenc
aris
highli
dynam
way
reach
suffici
level
modul
effect
affect
humor
cellular
immun
respons
becom
possibl
howev
occurr
requir
threshold
level
potenti
biolog
consequ
remain
larg
unexplor
kinet
viral
replic
relat
time
host
immun
respons
may
crucial
viru
clearanc
hcv
replic
rapidli
infect
host
often
preced
day
week
evok
immun
respons
mean
gener
hcv
antigen
variant
competit
among
continu
capac
specif
variant
becom
domin
process
diagrammat
repres
larg
arrow
fig
may
subtli
depend
time
gener
relat
intens
select
impos
cell
respons
outcom
may
either
perman
transient
clearanc
despit
vigor
intrahepat
cell
respons
thimm
et
al
process
paradox
natur
liver
immunobiolog
regard
immun
toler
versu
immun
surveil
must
taken
account
presenc
mainten
abor
ctlescap
mutant
viral
popul
influenc
viral
fit
least
two
way
fit
cost
entail
relev
mutat
correspond
amino
acid
substitut
b
differ
fit
level
attain
mutant
spectrum
minor
variant
virus
endow
antigen
profil
mechan
suggest
revers
epitop
mutat
either
later
stage
persist
infect
specif
ctl
pressur
wane
upon
transmiss
viru
individu
express
differ
mhc
allel
repertoir
borrow
et
al
friedrich
et
al
lesli
et
al
art
mechan
b
explor
vivo
document
model
studi
cell
cultur
experi
show
independ
possibl
fit
cost
entail
abescap
mutat
differ
fit
level
attain
variant
antigen
profil
affect
mutant
repertoir
select
neutral
monoclon
ab
stoichiometri
viral
particl
infect
target
cell
may
influenc
recognit
kill
infect
cell
specif
ctl
ctlescap
viru
mutant
coinfect
cell
wild
type
nonmut
epitop
viru
epitopespecif
ctl
recogn
infect
cell
cell
kill
prevent
replic
nonencapsid
viru
reach
extern
environ
render
biolog
void
presenc
ctlescap
mutant
possibl
suggest
given
multipl
viral
particl
often
infect
target
cell
gratton
et
al
given
multipl
implic
aband
ctlescap
viral
pathogen
justifi
hypothes
errorpron
natur
hcv
replic
intrins
persist
allow
rapid
evolut
adapt
immun
select
pressur
exert
host
bowen
walker
littl
question
addit
studi
carri
test
hypothesi
even
appear
genet
viral
variat
play
role
must
alway
recogn
persist
pathogen
vivo
result
complex
interplay
viral
host
influenc
mutant
decreas
sensit
antivir
inhibitor
isol
nearli
systemat
rna
viru
mani
dna
virus
review
domingo
previou
version
articl
extens
studi
case
due
dramat
consequ
medic
practic
resist
antiretrovir
agent
use
therapi
select
infect
patient
subject
antiretrovir
therapi
art
fit
cost
drugresist
mutat
influenc
perman
infect
organ
presenc
absenc
drug
mainten
genom
bear
debilit
drugresist
mutat
achiev
compensatori
mutat
nijhui
et
al
emerg
hbv
mutant
resist
antivir
inhibitor
gener
result
progress
liver
diseas
bartholomeusz
locarnini
subtitut
iv
viral
revers
transcriptas
rt
affect
catalyt
domain
ymdd
select
lamivudin
lnucleosid
resist
adefovir
associ
rt
substitut
key
substitut
confer
lamivudin
resist
hbv
locat
within
domain
c
polymeras
entail
decreas
replic
effici
compens
substitut
locat
domain
b
polymeras
allen
et
al
delaney
et
al
fu
cheng
sinc
hbv
rt
gene
overlap
hb
antigen
gene
drugresist
mutat
impact
function
medic
implic
drugmedi
mutant
larg
unexplor
bartholomeusz
locarnini
key
issu
concern
isol
hcv
mutant
decreas
sensit
nucleosid
analogu
ribavirin
use
antihcv
therapi
section
replac
phe
tyr
hcv
rdrp
isol
form
patient
treat
ribavirin
decreas
sensit
viru
nucleosid
analogu
fit
cost
mutat
suggest
reemerg
virus
patient
ribavirin
treatment
discontinu
resist
ribavirin
special
case
possibl
part
antihcv
activ
nucleosid
analogu
exert
via
mutagen
activ
lethal
mutagenesi
isol
virus
resist
ribavirin
impli
virus
potenti
escap
extinct
lethal
mutagenesi
discuss
section
advantag
combin
therapi
multipl
inhibitor
target
differ
viral
function
control
pathogen
virus
display
quasispeci
dynam
state
almost
two
decad
ago
domingo
current
advoc
control
infect
hepat
virus
locarnini
neyt
qureshi
earli
recogn
guidelin
addit
use
combin
therapi
includ
temporari
shelv
drug
tri
minim
circul
drugresist
viru
variant
limit
time
treatment
similar
concern
express
face
possibl
emerg
reemerg
viral
infect
rego
bonhoeff
obvious
time
requir
develop
resist
antivir
inhibitor
may
vari
differ
virus
differ
cycl
intrahost
replic
transmiss
select
resist
viral
mutant
direct
consequ
statist
consequ
quasispeci
dynam
see
calcul
approxim
frequenc
tripl
mutant
mention
section
support
experiment
theoret
consider
bonhoeff
et
al
coffin
et
al
realiz
need
combin
therapi
illustr
impact
understand
quasispeci
intrahost
popul
structur
independ
evolutionari
rate
consensu
sequenc
appli
virolog
clinic
practic
benefit
combin
therapi
evidenc
sustain
low
viral
load
mani
patient
infect
subject
highli
activ
antiretrovir
therapi
variou
form
unfortun
adapt
potenti
quasispeci
multipl
intrahost
reservoir
unceas
develop
inhibitorresist
viru
variant
follow
pace
isol
hbv
mutant
resist
lamivudin
allen
et
al
pallier
et
al
isol
ribavirinresist
mutant
hcv
predict
unless
lesson
taken
account
next
decad
wit
round
design
antihepat
viru
inhibitor
subsequ
circul
viru
variant
decreas
sensit
inhibitor
similar
concept
appli
immunotherapi
treatment
singl
neutral
monoclon
antibodi
mab
avoid
like
select
neutral
escap
mutant
virus
combin
two
neutral
antihcv
mab
recogn
differ
conform
epitop
suggest
prevent
reinfect
hcv
liver
transplant
patient
eren
et
al
efficaci
prophylact
treatment
expect
influenc
number
mutat
region
need
escap
neutral
mab
fit
cost
mutat
viral
load
involv
reinfect
mutant
virus
may
display
alter
virul
trait
associ
defin
genom
sequenc
despit
presenc
mutant
spectrum
literatur
describ
mani
exampl
includ
mutat
mediat
virul
polioviru
picornavirus
agol
traci
et
al
reveal
exampl
demonstr
molecular
clone
siv
copi
genom
virus
isol
macaqu
display
differ
degre
aidslik
diseas
reproduc
diseas
stage
origin
anim
inocul
macaqu
kimata
et
al
thu
complex
phenotyp
trait
imprint
defin
genom
sequenc
experi
adapt
swine
fmdv
guinea
pig
amino
acid
substitut
nonstructur
protein
directli
respons
adapt
new
host
ensu
patholog
independ
presenc
mutant
spectrum
shown
reproduc
diseas
administr
viru
express
infecti
clone
includ
relev
mutat
et
al
thu
adapt
mutat
mediat
emerg
reemerg
viral
diseas
alter
virul
independ
mutant
spectrum
complex
addit
exampl
domingo
parrish
kawaoka
differ
hcv
genotyp
subtyp
accumul
genet
signatur
render
exampl
genotyp
less
suscept
interferon
plu
ribavirin
therapi
genotyp
martinotpeignoux
et
al
poynard
et
al
effect
genotyp
distinct
effect
mutant
spectrum
complex
discuss
section
variat
hcv
function
consequ
mention
section
may
affect
cell
tropism
notabl
facilit
extrahepat
viru
replic
variat
ire
may
affect
translat
properti
viral
genom
differ
cell
tissu
review
pawlotski
evid
hcv
infect
may
associ
cardiac
disord
matsumori
et
al
matsumori
et
al
reinforc
concept
put
forward
decad
ago
mutant
form
rna
virus
associ
atyp
form
diseas
holland
et
al
worth
recal
statement
j
j
holland
colleagu
unspoken
assumpt
among
mani
physician
scientist
particular
rna
viru
gener
caus
particular
diseas
assumpt
may
true
broad
practic
sens
import
understand
never
true
formal
scientif
sens
particular
rna
viru
simpli
exist
particular
rna
viru
diseas
exist
either
scienc
infect
diseas
still
infanc
still
understand
littl
fine
detail
hostpathogen
interact
mutant
spectrum
viral
quasispeci
may
hide
mutant
whose
presenc
may
nevertheless
affect
viral
pathogenesi
individu
compon
vsv
quasispeci
display
either
higher
lower
capac
induc
interferon
averag
popul
natur
viral
isol
marcu
et
al
earli
exampl
predict
valu
quasispeci
complex
number
differ
sequenc
found
mutant
spectrum
coronaviru
mous
hepat
viru
correl
pathogen
potenti
mice
row
et
al
result
infect
mice
high
fidel
pv
mutant
pfeiffer
kirkegaard
vignuzzi
et
al
see
also
section
demonstr
mutant
spectrum
complex
may
per
se
virul
determin
hcv
complex
mutant
spectrum
may
affect
outcom
acut
infect
toward
chronif
respons
treatment
discuss
next
section
acut
hcv
infect
progress
chronic
infect
patient
subsequ
chronic
infect
lead
hepat
degre
liver
damag
transit
first
month
infect
acut
chronic
diseas
follow
longstand
diseas
transfus
recipi
farci
colleagu
demonstr
correl
transit
evolutionari
dynam
viru
clinic
outcom
farci
et
al
patient
infect
virus
underw
littl
evolut
acut
stage
infect
recov
complet
wherea
patient
viru
evolv
rapidli
develop
chronic
infect
author
conclud
divers
viral
popul
depend
host
immun
respons
respons
effect
divers
hcv
quasispeci
declin
final
variant
clear
find
prognost
valu
hepat
c
acquir
transfus
composit
quasispeci
follow
massiv
infect
transfus
recipi
close
match
infect
blood
unit
case
lasku
et
al
word
recipi
infect
well
structur
quasispeci
may
case
infect
transmiss
rout
size
viral
inoculum
small
mutat
accumul
without
possibl
effect
select
ultim
viral
spectrum
heterogen
extinct
case
fittest
viru
may
never
found
ma
et
al
observ
interpret
accord
error
catastroph
theori
et
al
discuss
section
replic
system
accept
maximum
averag
error
rate
without
lose
encod
inform
mutat
frequenc
rna
virus
suggest
might
replic
near
error
threshold
occas
might
briefli
exceed
eigen
biebrich
holland
propos
colleagu
could
provid
explan
spontan
resolut
infect
nontransfus
patient
expos
hcv
fact
recoveri
appear
common
among
patient
expos
small
inocula
produc
accident
needl
stick
intraven
drug
use
sexual
transmiss
among
infect
larg
viru
dose
low
risk
persist
exposur
seroconvers
sexual
transmiss
associ
small
number
viral
particl
carri
limit
combin
mutat
unstructur
quasispeci
may
decreas
potenti
overcom
immun
respons
expos
host
quer
et
al
although
precis
factor
influenc
viral
clearanc
persist
well
understood
signific
associ
found
broad
sustain
hcvspecif
cell
respons
viral
clearanc
acut
hepat
c
infect
addit
mode
transmiss
may
one
factor
determin
transit
acut
persist
infect
progress
liver
diseas
patient
chronic
hcv
infect
report
like
patient
durat
infect
longer
men
older
patient
hiv
hbv
coinfect
consum
alcohol
among
virusrel
factor
neither
viral
concentr
viral
genotyp
indic
like
progress
point
hcvrna
level
stabl
hcv
chronic
carrier
small
proport
patient
signific
viral
load
fluctuat
yeo
et
al
amino
acid
sequenc
code
junction
region
quasispeci
serum
liver
group
cluster
repres
histogram
group
made
accord
similar
amino
acid
sequenc
subgroup
share
one
amino
acid
replac
present
togeth
amino
acid
sequenc
subset
sampl
intergroup
amino
acid
sequenc
consist
one
two
substitut
intragroup
amino
acid
sequenc
differ
singl
point
substitut
color
pattern
identifi
ident
subgroup
mutat
consensu
sequenc
viral
quasispeci
time
shown
bottom
histogram
symbol
repres
one
mutat
shannon
entropi
genet
distanc
shown
respect
histogram
base
cabot
et
al
sever
studi
tri
correl
complex
circul
quasispeci
degre
liver
damag
cabot
et
al
gonzalezperalta
et
al
hayashi
et
al
koizumi
et
al
lopezlabrador
et
al
naito
et
al
qin
et
al
yuki
et
al
although
report
suggest
higher
rate
progress
among
patient
infect
complex
quasispeci
latter
probabl
reflect
diseas
durat
observ
may
fit
theoret
model
viral
diversif
antigen
variant
complet
replac
emerg
one
continu
accumul
variant
could
reflect
histori
immun
evas
cell
destruct
nowak
schuster
nowak
et
al
studi
involv
larg
cohort
patient
complex
quasispeci
correl
alt
level
could
mean
complex
could
relat
immunemedi
liver
injuri
rothman
et
al
sever
depth
studi
depict
complex
situat
encourag
expect
reach
good
correl
quasispeci
complex
degre
liver
damag
first
composit
circul
viral
popul
alway
reflect
composit
hepat
popul
cabot
et
al
jang
et
al
maggi
et
al
roqueafonso
et
al
second
patient
extrahepat
replic
may
repres
import
contribut
complex
circul
quasispeci
deforg
et
al
forton
et
al
pal
et
al
third
continu
reorganis
quasispeci
structur
period
rel
stabil
patient
sporad
variat
major
minor
variant
other
seem
frequent
cabot
et
al
franco
et
al
fig
fourth
reappear
memori
variant
respond
vu
extern
stimuli
ruizjarabo
et
al
may
induc
quick
shift
composit
popul
shown
case
brion
et
al
reinocul
studi
chronic
hcvinfect
chimpanze
preexist
slower
replic
quasispeci
outliv
fasterrepl
variant
second
inocul
may
good
exampl
memori
properti
hcv
wyatt
et
al
indirect
evid
involv
memori
genom
found
longitudin
evalu
replic
quasispeci
chronic
infect
patient
cabot
et
al
franco
et
al
thu
even
though
quasispeci
evolut
may
associ
progress
acut
chronic
hepat
c
conclus
evid
quasispeci
evolut
diversif
caus
role
diseas
progress
cirrhosi
chronic
hepat
c
develop
nevertheless
note
vast
major
studi
aim
defin
role
quasispeci
structur
pathogenesi
chronic
hcv
infect
focus
hypervari
region
viral
gene
better
understand
virushost
interact
crucial
capac
hcv
rapid
errorpron
replic
mechan
inhibit
chemokin
product
rel
induct
type
ifn
versu
mechan
hcv
resist
type
ifn
well
number
induc
host
gene
intertwoven
lead
either
clearanc
chronif
viru
rehermann
nascimbeni
interferon
singl
agent
combin
interferon
nucleosid
analogu
ribavirin
use
treat
chronic
hepat
c
infect
ribavirin
ineffect
caus
transient
decreas
viral
load
use
alon
combin
interferon
ifn
least
doubl
decreas
viral
load
reach
compar
durat
ifn
monotherapi
better
clinic
result
achiev
introduct
polyethylenglycol
peg
modifi
ifnalfa
plu
ribavirin
patient
genotyp
genotyp
reach
sustain
virolog
respons
absenc
detect
hcv
rna
serum
pawlotski
ifnalfa
least
two
type
antivir
effect
first
immunomodulatori
action
enhanc
antivir
immun
respons
second
induct
antivir
state
infect
cell
variou
pathway
one
extens
investig
pathway
induct
doublestrand
rnaactiv
protein
kinas
r
pkr
lead
inhibit
cellular
protein
synthesi
phosphoryl
translat
initi
factor
action
ribavirin
may
relat
either
capac
modul
immun
respons
mutagen
activ
viral
rna
synthesi
crotti
et
al
crotti
et
al
graci
cameron
parker
next
section
sustain
respons
ifnalfa
plu
ribavirin
treatment
like
patient
shorter
durat
diseas
younger
milder
liver
histolog
damag
among
virolog
factor
low
viral
load
hcv
genotyp
optim
condit
sustain
respons
respect
influenc
viral
quasispeci
sustain
respons
sever
studi
focus
complex
number
variant
divers
mean
genet
distanc
variant
viral
popul
baselin
studi
address
dynam
quasispeci
initi
treatment
variat
evolut
specif
genom
region
potenti
mediat
drug
resist
viral
paramet
also
analys
combin
paramet
defin
host
immun
respons
next
review
approach
okada
et
al
first
report
degre
variabl
region
gene
correl
interferon
respons
sever
studi
confirm
correl
quasispeci
complex
respons
interferon
therapi
patient
complex
popul
enomoto
et
al
kanazawa
et
al
koizumi
et
al
le
guen
et
al
greater
degre
intrapopul
diverg
polyak
et
al
respond
less
well
respond
treatment
avail
combin
pegifn
ribavirin
provid
effect
antivir
respons
led
reevalu
issu
quasispeci
predict
factor
respons
treatment
farci
et
al
question
whether
pretreat
viral
divers
could
predict
final
respons
found
interest
associ
reduct
quasispeci
divers
treatment
start
viral
clearanc
reduct
prognost
valu
result
contrast
vari
pattern
quasispeci
evolut
respond
found
chamber
et
al
studi
larg
cohort
patient
show
increas
quasispeci
divers
togeth
activ
specif
antihcv
immun
statu
start
therapi
associ
poor
virolog
respons
morishima
et
al
consist
idea
immun
respons
drive
quasispeci
divers
vivo
also
may
provid
light
interpret
differ
result
studi
involv
lower
number
patient
major
studi
analys
implic
hcv
quasispeci
respons
antivir
treatment
focus
gene
enomoto
et
al
suggest
genet
heterogen
specif
domain
nonstructur
region
hcv
known
ifn
sensitivitydetermin
region
isdr
close
relat
respons
treatment
japanes
patient
hcv
genotyp
infect
issu
rais
controversi
studi
western
countri
chamber
et
al
squadrito
et
al
puigbasago
et
al
saiz
et
al
infect
patient
sustain
virolog
respons
show
mutat
within
isdr
region
sequenc
adjac
isdr
domain
may
involv
pkr
bind
thu
link
ifn
resist
even
though
region
may
play
role
hcv
resist
naturallysecret
ifn
confirm
region
contain
determin
block
administ
ifnalfa
nousbaum
et
al
anoth
studi
taylor
et
al
demonstr
envelop
protein
hcv
genotyp
contain
sequenc
similar
pkr
autophosphoryl
site
phosphoryl
site
translat
initi
factor
latter
target
pkr
name
pephd
domain
author
show
genotyp
hcv
type
isol
interact
inhibit
kinas
activ
pkr
cell
cellfre
system
nevertheless
seem
mutat
pattern
region
influenc
respons
ifnalfa
quer
et
al
could
emerg
mutat
region
correl
treatment
outcom
thu
sequenc
region
treatment
use
predict
success
treatment
gaudi
et
al
antivir
effect
infalfa
ribavirin
act
directli
viral
protein
rna
instead
indirect
action
varieti
cellular
antivir
activ
immun
respons
stimul
like
drug
exert
select
pressur
particular
viral
sequenc
case
would
difficult
establish
defin
pattern
mutat
specif
viral
region
associ
treatment
failur
hiv
patient
treat
haart
one
consequ
quasispeci
dynam
exist
error
threshold
relationship
mainten
genet
inform
recent
review
biebrich
eigen
biebrich
eigen
error
rate
exceed
toler
limit
depend
genom
size
rel
viral
fit
popul
size
collaps
entir
quasispeci
distribut
nucleotid
sequenc
lose
inform
content
transit
term
entri
error
catastroph
applic
viru
extinct
enhanc
mutagenesi
term
lethal
mutagenesi
review
anderson
et
al
domingo
eigen
guid
extens
theoret
work
first
demonstr
advers
effect
enhanc
mutagenesi
viral
replic
obtain
holland
et
al
work
polioviru
vsv
use
mutagen
agent
act
differ
mechan
includ
base
nucleosid
analogu
show
mutat
frequenc
defin
nucleotid
site
viral
genom
could
increas
modestli
without
sever
loss
infect
result
extend
loeb
et
al
number
rna
virus
display
differ
replic
mechan
review
anderson
et
al
domingo
two
relev
advanc
area
research
boost
interest
lethal
mutagenesi
antivir
strategi
one
discoveri
ribavirin
extens
use
antihcv
therapi
section
act
mutagen
agent
virus
crotti
et
al
graci
cameron
sinc
ribavirin
licens
drug
ampli
use
treat
sever
viral
infect
possibl
case
antivir
activ
exert
contribut
mutagenesi
key
question
whether
ribavirin
may
exert
antihcv
activ
particip
lethal
mutagenesi
evid
ribavirin
induc
errorpron
replic
gb
viru
b
primari
tamarin
hepatocyt
lanford
et
al
mycophenol
acid
ribavirin
inhibitor
inosin
monophosph
dehydrogenas
result
reduc
intracellular
gtp
pool
antivir
effect
virion
ribavirintr
cultur
show
dramat
reduct
specif
infect
inhibit
replic
increas
mutat
frequenc
quantit
fulllength
subgenom
hcv
replicon
contrera
et
al
kanda
et
al
zhou
et
al
hcv
polymeras
catalyz
incorpor
ribavirin
monophosph
opposit
cytidin
uridin
vitro
maag
et
al
templat
contain
ribavirin
direct
incorpor
cmp
ump
equal
effici
also
caus
signific
block
rna
elong
result
purifi
suggest
hcv
replic
machineri
ingredi
ribavirin
triphosph
act
inhibitor
mutagen
hcv
rna
synthesi
maag
et
al
vo
et
al
favor
direct
action
ribavirinnucleotid
vivo
isol
mutant
increas
resist
ribavirin
specif
amino
acid
replac
enzym
probabl
impli
fit
cost
see
also
section
second
relev
advanc
mutagen
base
analogu
prevent
establish
persist
lcmv
infect
mice
ruizjarabo
et
al
proofofprincipl
feasibl
antivir
approach
vivo
base
concept
error
catastroph
recognit
ribavirin
mutagen
agent
virus
encourag
addit
experiment
studi
lethal
mutagenesi
studi
provid
evid
increas
mutat
frequenc
hcv
patient
treat
ribavirin
asahina
et
al
studi
found
signific
increas
relev
consider
effect
ribavirinnucleotid
concentr
attain
vivo
site
hcv
replic
rel
concentr
found
effect
cell
cultur
possibl
intervent
host
factor
may
alter
behavior
other
hong
studi
hiv
popul
addit
patient
extens
hcv
quasispeci
analysi
need
clarifi
import
point
parallel
number
studi
rna
virus
explor
molecular
mechan
underli
lethal
mutagenesi
main
conclus
studi
transit
toward
extinct
occur
decreas
specif
infect
ratio
infecti
total
genom
without
modif
consensu
sequenc
variabl
increas
mutant
spectrum
complex
b
case
compar
studi
carri
viru
extinct
depend
mutagen
action
mere
inhibitori
activ
manifest
mutagen
document
incapac
inhibitori
combin
extinguish
viru
despit
reach
degre
inhibit
attain
presenc
mutagen
agent
mediat
extinct
c
viral
extinct
facilit
low
viral
fit
low
viral
load
preextinct
viral
rna
mutagen
viral
popul
prior
extinct
interfer
infect
observ
review
anderson
et
al
domingo
domingo
support
view
mutagenesi
sole
inhibit
viral
replic
mediat
viral
extinct
accord
paramet
effect
viral
load
viral
fit
includ
error
threshold
relationship
biebrich
eigen
eigen
studi
extinct
lymphocyt
choriomening
viru
lcmv
persist
infect
cell
suggest
presenc
defect
lcmv
genom
could
contribut
elimin
viru
et
al
experiment
result
base
decreas
viru
infect
preced
decreas
viru
replic
support
silico
model
studi
use
realist
paramet
view
viral
extinct
lethal
mutagenesi
would
facilit
lethal
mutat
debilit
mutat
could
exert
deleteri
effect
quasispeci
whole
neg
effect
defect
genom
view
extrem
case
suppress
effect
mutant
spectrum
discuss
section
et
al
et
al
lethal
mutagenesi
nucleosid
analogu
open
interest
connect
antivir
therapi
cancer
chemotherapi
clinic
trial
nucleosid
analogu
current
way
aid
patient
harri
et
al
given
multipl
therapeut
option
open
control
hcv
neyt
qureshi
gener
observ
benefit
combin
therapi
possibl
combin
classic
approach
lethal
mutagenesi
principl
appeal
much
depend
find
virusspecif
agent
limit
cell
toxic
deeper
understand
host
compon
involv
respons
infect
hepat
virus
quasispeci
dynam
impact
biolog
hepat
virus
reflect
review
extent
howev
escap
variant
contribut
viral
persist
diseas
progress
treatment
effect
affect
natur
complex
mutant
spectra
open
question
approach
import
problem
learn
virus
taken
consider
dynam
behavior
mutant
spectra
interact
host
organ
basic
presid
univers
darwinian
principl
appli
system
simpl
replicon
display
errorpron
replic
mani
import
question
address
contribut
better
understand
hepat
virus
plan
control
strategi
level
basic
replic
mechan
would
import
defin
fidel
properti
polymeras
catalyz
hepat
viru
replic
definit
replic
complex
involv
host
factor
replic
would
open
way
design
new
antivir
inhibitor
exampl
interfer
critic
polymerasehost
factor
interact
drug
capabl
decreas
copi
fidel
replic
machineri
favor
transit
error
catastroph
obvious
clarif
mechan
action
ribavirin
administ
togeth
ifn
deriv
drug
may
also
provid
new
insight
treatment
strategi
contribut
cellular
antibodi
immun
respons
viru
clearanc
viral
host
factor
prevent
clearanc
certainli
address
find
area
essenti
design
prevent
therapeut
vaccin
plan
combin
treatment
may
involv
guidanc
immun
respons
togeth
suppress
viral
replic
necessit
lot
basic
research
number
interconnect
area
quasispeci
provid
interpret
capac
hepat
virus
adapt
chang
environ
live
host
open
wealth
new
question
viral
respons
toward
adapt
may
either
succeed
fail
regard
viru
mainten
